Larimar Therapeutics
Manufacturing · Pennsylvania, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
3 Bala Plz Ste 506, Bala Cynwyd, Pennsyl...Phone Number
(844) 511-9056Website
www.larimartx.comRevenue
-Stock Symbol
LRMRIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Larimar Therapeutics
Larimar Therapeutics is a clinicalstage biotechnology company that focuses on discovering and developing innovative treatments for complex rare diseases using a proprietary intracellular delivery platform designed to transport therapeutic molecules into cells. The companys core mission centers on addressing serious unmet medical needs by advancing novel protein replacement therapies, with its lead program aimed at treating a debilitating genetic disorder through targeted delivery of a therapeutic protein. Larimar emphasizes rigorous scientific research and collaboration with regulatory authorities and research partners to progress its development programs and expand its pipeline of potential therapies for patients with limited treatment options.Explore more
Larimar Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Larimar Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Larimar Therapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Larimar Therapeutics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Larimar Therapeutics
Larimar Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Larimar Therapeutics launches new products
Check out if Larimar Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once Larimar Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Check if Larimar Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Larimar Therapeutics
Find 2 more new buyers
Compare Similar Companies to Larimar Therapeutics
Compare insights from companies similar to Larimar Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Larimar Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Larimar Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Larimar Therapeutics.
Larimar Therapeutics financials insights
Gather financial insights about Larimar Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Stock Offering
$172.5M
Larimar Therapeutics Tech Stack
A closer look at the technologies used by Larimar Therapeutics
See more technologies
Most Recent Scoops
Open Position
Project
Larimar Therapeutics has announced that nomlabofusp, a recombinant fusion protein designed to address frataxin deficiency in Friedreich's ataxia by delivering the frataxin protein across the cell membrane into the mitochondria.
Pharmaceuticals
Open Position
Person-Based
Clinical Operations
Open Position
Larimar Therapeutics News & Media
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR
NEW YORK, July 9, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Larimar Therapeutics, Inc. ("Larimar" or the "Company") (NASDAQ: LRMR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR
NEW YORK, July 1, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Larimar Therapeutics, Inc. ("Larimar" or the "Company") (NASDAQ: LRMR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...Larimar Therapeutics Reports Positive Open Label Data and Submission of First Module of Rolling BLA for Accelerated Approval of Nomlabofusp for Friedreich’s Ataxia
BALA CYNWYD, Pa., June 29, 2026 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced it has submitted the first module of its rolling Biologics License Application (BLA) submission to the Food and Drug Administration (FDA) for accelerated approval of nomlabofusp; the remaining modules are expected to be submitted in the second half of 2026. The submission was madLarimar Therapeutics Announces Investor Event on the Nomlabofusp Program for Friedreich’s Ataxia
BALA CYNWYD, Pa., June 26, 2026 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that the Company will host an investor event to discuss updates for the Company’s nomlabofusp clinical development program including a regulatory update and data from the ongoing long-term open label study for the treatment of Friedreich’s ataxia on Monday, June 29, 2026 at 7:45
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Larimar Therapeutics
Sign Up For FreeTo access detailed company insights
Larimar Therapeutics is a clinicalstage biotechnology company that focuses on discovering and developing innovative treatments for complex rare diseases using a proprietary intracellular delivery platform designed to transport therapeutic molecules into cells. The companys core mission centers on addressing serious unmet medical needs by advancing... Read More
